Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ranbaxy Laboratories
Officials from Ranbaxy Laboratories provide details of new developments
February 14th, 2007
Officials from Ranbaxy Laboratories provide details of new developments. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Ranbaxy Laboratories. Report 1: Ranbaxy Laboratories Limited announced that the company has received tentative approval from the U.S. Food and Drug Administration (FDA) to manufacture and market cetirizine hydrochloride syrup, 5 mg/5 mL. Total annual market sales for cetirizine hydrochloride syrup were $146.3 million. Cetirizine hydrochloride syrup is indicated for the relief of symptoms associated with seasonal allergic rhinitis due to...
Source: Medical Patent Law Weekly (2007-02-14)
|
